Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. (2023)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers15061845
PubMed Identifier: 36980732
Publication URI: http://europepmc.org/abstract/MED/36980732
Type: Journal Article/Review
Volume: 15
Parent Publication: Cancers
Issue: 6
ISSN: 2072-6694